Title : SIRT5 as a biomarker for response to anthracycline-taxane-based neoadjuvant chemotherapy in triple-negative breast cancer.

Pub. Date : 2018 May

PMID : 29565454






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 SIRT5 as a biomarker for response to anthracycline-taxane-based neoadjuvant chemotherapy in triple-negative breast cancer. taxane sirtuin 5 Homo sapiens
2 Thus, we speculated that SIRT5 may be a potential predictive marker of the response to anthracycline-taxane-based chemotherapy. taxane sirtuin 5 Homo sapiens
3 In conclusion, the present study revealed SIRT5 as a biomarker for response to anthracycline-taxane-based NAC in patients with TNBC and identified a series of novel biological functions of SIRT5 in breast cancer. taxane sirtuin 5 Homo sapiens